Multiple studies have demonstrated racial/ethnic minority individuals receive less treatment for similar levels of pain than non-Hispanic white (NHW) individuals. Whether this association exists in the postpartum setting remains unknown. We sought to evaluate racial/ethnic differences in women's postpartum pain scores, inpatient opioid administration, and discharge opioid prescribing. STUDY DESIGN: Retrospective cohort study of all deliveries at a single, high-volume tertiary care center (12/2015-16). Women were included if they self-identified as NHW, non-Hispanic black (NHB), or Hispanic. Medical records were queried for three outcomes: 1) patient-reported postpartum pain score at discharge (dichotomized <5 or 5); 2) inpatient opioid dosing during postpartum hospitalization (reported as morphine milligram equivalents [MME] per postpartum day); and 3) receipt of an opioid prescription at discharge. The associations between each of these outcomes and maternal race/ethnicity were assessed using multivariable logistic regression models with random effects to account for clustering by discharge physician. RESULTS: Of 9,900 women eligible for analysis, 68.4% identified as NHW, 21.0% as Hispanic, and 10.6% as NHB. On bivariable analyses, Hispanic and NHB women were more likely to report postpartum pain scores 5 (p<0.001), but received less inpatient MME/ day (p<0.001) and were less likely to receive an opioid prescription at discharge than NHW women (p<0.001) (Figure) . On multivariable analyses, these findings remained statistically significant (Table) . Specifically, compared to NHW women, Hispanic women had significantly greater odds of reporting a pain score of 5 (aOR 1.69; 95% 1.33-2.15), but received significantly less inpatient MME/day (ab -4.77; 95% CI -6.59 to -0.62) and were significantly less likely to receive an opioid prescription at discharge (aOR 0.81; 95% CI 0.68-0.97). Similarly, NHB women had significantly greater odds of reporting a pain score 5 (aOR 2.66; 95% 2.05-3.45), but received significantly less inpatient MME/day (ab -2.79; 95% CI -4.95 to -0.62) and were significantly less likely to receive an opioid prescription at discharge (aOR 0.81; 95% CI 0.65-0.99). CONCLUSION: Hispanic and NHB women experience disparities in pain management in the postpartum setting that cannot be explained by less perceived pain.
OBJECTIVE: Professional guidelines and IL state law require screening for sexually transmitted (STI) infection during pregnancy. Our objective was to evaluate adherence to STI screening recommendations during pregnancy and identify factors associated with adherent screening. STUDY DESIGN: Retrospective cohort study of women with singleton gestations who initiated prenatal care in the first or second trimester between 11/2011-2015. Demographic characteristics and STI screening were abstracted from prenatal records. Tests of interest included initial syphilis, HIV, hepatitis B, chlamydia and gonorrhea (GCCT) and repeat (third trimester) syphilis and HIV. All women were eligible for initial screening. Women were considered eligible for repeat screening for syphilis (mandated by state law) and HIV (institutional protocol) if delivered 32 wks. Adherent screening was defined as performance of all recommended screening; initial and repeat testing were analyzed separately. Factors associated with adherent screening were evaluated using multivariable logistic regression models. RESULTS: Of 2370 women in the total cohort, 1809 (76.3%) received adherent initial STI screening and 181 (7.6%) received adherent repeat STI screening. Women who received initial screening were more likely to be older, non-Hispanic white, non-smokers who initiated care earlier. After adjusting for covariates, being privately insured (aOR 1.74, 95% CI 1.38-2.21) was significantly associated with adherent initial screening, whereas being non-Hispanic or Hispanic were associated with lower odds of adherent initial screening (Table) . 
